Skip to main navigation
Madrigal Pharmaceuticals Madrigal Pharmaceuticals.
  • About Us
    • Overview
    • Leadership
    • Board Of Directors
  • Our Programs
    • Overview
    • Our Medicine
  • NASH
    • Overview
    • Resources
  • Investors & Media
    • Overview
    • Press Releases
    • Events and Presentations
    • Financials and Filings
    • Stock Information
    • Corporate Governance
    • FAQs
    • Email Alerts
  • Careers
    • Join the team
    • Core Values
  • Contact
    • General Inquires
    • Medical Information Inquiries
    • Medical Education Grant Submissions
Search
  • About Us
    • Overview
    • Leadership
    • Board Of Directors
  • Our Programs
    • Overview
    • Our Medicine
  • NASH
    • Overview
    • Resources
  • Investors & Media
    • Overview
    • Press Releases
    • Events and Presentations
    • Financials and Filings
    • Stock Information
    • Corporate Governance
    • FAQs
    • Email Alerts
  • Careers
    • Join the team
    • Core Values
  • Contact
    • General Inquires
    • Medical Information Inquiries
    • Medical Education Grant Submissions
  • Overview
  • Press Releases
  • Events and Presentations
  • Financials and Filings
  • Stock Information
  • Corporate Governance
  • FAQs
  • Email Alerts
Presentations
Third-Quarter 2024 Financial Results Presentation
October 30, 2024
Second-Quarter 2024 Financial Results Presentation
August 7, 2024
Rezdiffra Approval Presentation
March 14, 2024
Upcoming Events
More events are coming soon.
Archived Events
43rd Annual J.P. Morgan Healthcare Conference
5:15 PM EST
Listen to Webcast
Press Release 804.7 KB
43rd Annual J.P. Morgan Healthcare Presentation 1.3 MB
Piper Sandler 36th Annual Healthcare Conference
8:30 AM EST
Listen to Webcast
7th Annual Evercore HealthCONx Conference
9:35 AM EST
Listen to Webcast
UBS Global Healthcare Conference 2024
2:00 PM EST
Listen to Webcast
Q3 2024 Earnings Call
8:00 AM EDT
Listen to Webcast
Third-Quarter 2024 Financial Results Presentation 375.7 KB
Press Release 118.1 KB
H.C. Wainwright & Co. 8th Annual MASH Investor Conference
2:00 PM EDT
Listen to Webcast
Morgan Stanley 22nd Annual Global Healthcare Conference
10:45 AM EDT
Listen to Webcast
Q2 2024 Earnings Call
8:00 AM EDT
Listen to Webcast
Second-Quarter 2024 Financial Results Presentation 498.2 KB
Press Release 287.3 KB

Madrigal’s ambitious research programs led to the first FDA-approved treatment in NASH.

Learn More
Madrigal Pharmaceuticals. Logo

Madrigal Pharmaceuticals

200 Barr Harbor Drive,
Suite 200

West Conshohocken,
Pennsylvania 19428

  • About Us
  • Our Programs
  • NASH
  • Investors & Media
  • Careers
  • Contact
Madrigal Pharmaceuticals
  • Terms of Use
  • Privacy
  • Cookies
  • ETHICS and COMPLIANCE
  • TRANSPARENCY
©2025 Madrigal Pharmaceuticals. All rights reserved.